We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App





Greiner Bio-One Highlights Latest Innovations in Sample Collection and Safety Products

By LabMedica International staff writers
Posted on 22 Jul 2023

Greiner Bio-One (Monroe, NC, USA) is presenting its innovative collection systems and safety products for venous and capillary blood and urine samples at AACC 2023. More...

The company is also highlighting its research workflow solutions, including specialized products for the cultivation of cell cultures, microplates for high-throughput screening, biobanking solutions, and more.

At AACC 2023, Greiner is showcasing its new VACUETTE CAT Serum Fast Separator enables the complete clotting of the whole blood sample in just five minutes, offering a decisive time advantage compared to conventional serum tubes. By combining the speed of a plasma tube with the advantages of serum quality in terms of erythrocytes remaining after centrifugation, it considerably shortens the preanalytical process and saves enormous amounts of time. Thanks to the short clotting time of just five minutes, followed by centrifugation for five minutes, the analysis of key clinical chemical parameters can begin after just 10 minutes, allowing reliable results to be attained far quicker. This makes it easy to effectively reduce turnaround time (TAT) by 30 minutes per sample and targeted treatment can be initiated more rapidly.

Greiner is highlighting its Sapphire product family of pipette tips, filter tips, and low retention tips. Sapphire tips are manufactured in eight different sizes with volume ranges extending from 10 µl to 1250 µl, including an extended length 10 µl tip for the recovery of small sample volumes. To ensure optimal functionality and fit, Sapphire pipette tips are made of high-quality polypropylene. Greiner is demonstrating its magnetic 3D cell culture solutions based on the magnetization of cells with NanoShuttle-PL. The magnetized cells can be aggregated by magnetic forces, either by levitation or bioprinting, to form micro physiologically relevant 3D models in vitro. The magnetic system overcomes the limitations of other platforms by enabling the manipulation of cells for the rapid formation of spheroids, reproducible and scalable in size for high throughput, without restrictions of cell type.

Also on display at the Greiner booth is the new ThinCert 96 well HTS insert which is the optimal tool for scientists who want to generate tissue models (e.g., endothelia and epithelia) for transport, uptake, or co-culture studies in submersed as well as air-lift culture with an automation-friendly format. The two-component system comprises a 96-well porous membrane plate manufactured entirely from polycarbonate (PC) and a corresponding polystyrene (PS) receiver plate. The tissue culture-treated PC membrane allows for an ideal exchange of nutrients and substances, creating in vivo-like cultivation conditions to facilitate optimal cell growth, monolayer formation, and tissue differentiation.

Related Links:
Greiner Bio-One 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Manual Pipetting Aid
Pipette Controllers macro
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.